| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $8,905,297 ) (Continued on the next page) |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01AG087104 | A Prospective Observational Cohort Study to Evaluate and Predict Oropharyngeal Dysphagia (OD) Improvement in Hospitalized Patients with Alzheimer's disease and related Dementias (AD/ADRD) | 000 | 2 | NIH | 1/30/2026 | $739,292 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R35GM157197 | T Cell Receptor Mediated T Cell Activation in Neonatal and Pediatric Sepsis | 001 | 2 | NIH | 3/20/2026 | $41,875 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R35GM157197 | T Cell Receptor Mediated T Cell Activation in Neonatal and Pediatric Sepsis | 000 | 2 | NIH | 12/19/2025 | $376,875 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R35HL171168 | Cellular and Molecular Control of Normal and Disordered Erythropoiesis | 000 | 3 | NIH | 2/13/2026 | $827,016 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21AI196430 | Maturation and maintenance of the germinal center niche | 000 | 1 | NIH | 2/10/2026 | $460,625 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R13MH132238 | Critical Research Issues in Latino Mental Health/American Society of Hispanic Psychiatry | 000 | 4 | NIH | 3/5/2026 | $10,000 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R13MH132238 | Critical Research Issues in Latino Mental Health/American Society of Hispanic Psychiatry | 000 | 4 | NIH | 3/5/2026 | $20,000 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01NS136685 | Selective, Epineural Stimulation of Peripheral Nerves with Interferential Electrical Fields | 001 | 2 | NIH | 3/2/2026 | $59,638 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01NS136685 | Selective, Epineural Stimulation of Peripheral Nerves with Interferential Electrical Fields | 000 | 2 | NIH | 1/21/2026 | $536,757 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH138682 | Development of Cerebellar-Cortical Functional Connectivity in Youth and Its Prediction of Psychosis | 000 | 2 | NIH | 1/15/2026 | $419,953 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH138636 | Elucidating Reward Network Modulation in Medial Forebrain Bundle Deep Brain Stimulation for Treatment Resistant Depression | 000 | 2 | NIH | 1/22/2026 | $608,033 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH117646 | Cognitive Genomics as a Window on Neurodevelopment and Psychopathology | 000 | 8 | NIH | 2/10/2026 | $631,056 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL139778 | Therapeutic Potential of ALK1 Activating Drugs in HHT Models | 000 | 6 | NIH | 3/27/2026 | $558,494 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL162912 | Kids: Nocturnal Investigation into Glomerular Disease, Hypertension, and Transcriptomics (kNIGHT) | 001 | 4 | NIH | 3/27/2026 | $711,803 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL076179 | Improvement of Organ Function after Severe Hypovolemia | 000 | 17 | NIH | 2/23/2026 | $514,454 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01DK131482 | Dissecting the heterogeneity and function of myeloid cells in lupus nephritis | 000 | 4 | NIH | 1/12/2026 | $658,149 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01DA063076 | Single cell dark matter in the context of HIV and substance use | 001 | 2 | NIH | 4/1/2026 | $589,176 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01CA236591 | Cellular interactions between TGF-beta pathway members and epigenetic regulators in liver and gastrointestinal cancers | 000 | 8 | NIH | 3/23/2026 | $418,750 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01AG087104 | A Prospective Observational Cohort Study to Evaluate and Predict Oropharyngeal Dysphagia (OD) Improvement in Hospitalized Patients with Alzheimer's disease and related Dementias (AD/ADRD) | 001 | 2 | NIH | 2/25/2026 | $82,142 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | U01AI186997 | Ghrelin as Radiation Countermeasure: Mechanism of Its Action | 000 | 2 | NIH | 12/24/2025 | $586,240 |
| | 2026 | 2026 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K23DK132459 | Using Digital Solutions to Improve Transition of Care for Patients with Acute Kidney Injury | 000 | 5 | NIH | 3/25/2026 | $188,293 |
| | 2026 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UM1HL147371 | Advancing Cardiothoracic Surgical Trials in Rural Health Populations | 002 | 7 | NIH | 2/25/2026 | $0 |
| | 2026 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UM1HL147371 | Advancing Cardiothoracic Surgical Trials in Rural Health Populations | 001 | 7 | NIH | 12/29/2025 | $0 |
| | 2026 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UM1HL147371 | Advancing Cardiothoracic Surgical Trials in Rural Health Populations | 000 | 7 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UG1CA189850 | Northwell Health NCORP | 000 | 11 | NIH | 1/29/2026 | $0 |
| | 2026 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R33AG079930 | Reducing Burden in Care Partners of Community-Dwelling Persons with Dementia and Oropharyngeal Dysphagia | 000 | 3 | NIH | 2/6/2026 | $0 |
| | 2026 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21MH135148 | Tau biomarkers in late-onset psychosis | 000 | 2 | NIH | 12/5/2025 | $0 |
| | 2026 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R13HD048170 | David W. Smith Workshop on Malformations and Morphogenesis | 000 | 20 | NIH | 12/18/2025 | $0 |
| | 2026 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL162912 | Kids: Nocturnal Investigation into Glomerular Disease, Hypertension, and Transcriptomics (kNIGHT) | 000 | 3 | NIH | 2/12/2026 | $0 |
| | 2026 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01DA063076 | Single cell dark matter in the context of HIV and substance use | 000 | 1 | NIH | 3/20/2026 | $0 |
| | 2026 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01CA260691 | Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma | 001 | 5 | NIH | 3/23/2026 | $0 |
| | 2026 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K23MH130750 | Advancing Computational Linguistic Biomarkers of Disorganized Speech in Psychosis | 000 | 4 | NIH | 12/22/2025 | $0 |
| | 2026 | 2025 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K08AI193352 | Comparison of the Dysregulated and Regulated Host Responses to Infection | 000 | 1 | NIH | 2/18/2026 | $0 |
| | 2026 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UG3OD035513 | Developmental Impact of NICU Exposures (DINE) phase II | 000 | 2 | NIH | 12/1/2025 | $0 |
| | 2026 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | UG3OD035532 | The Environmental Factors in FEtal to Childhood Trajectories Cohort | 000 | 2 | NIH | 12/16/2025 | $0 |
| | 2026 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R61AG079930 | Reducing Burden in Care Partners of Community-Dwelling Persons with Dementia and Oropharyngeal Dysphagia | 000 | 2 | NIH | 1/28/2026 | $0 |
| | 2026 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HG011711 | Polygenic Embryo Screening: Towards Informed Decision-Making | 000 | 4 | NIH | 3/20/2026 | $0 |
| | 2026 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01GM137203 | Preoperative exercise therapy for surgery triggered inflammation | 000 | 5 | NIH | 1/26/2026 | $0 |
| | 2026 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01GM143362 | Encoding of inflammatory mediators by vagal sensory neurons | 000 | 4 | NIH | 3/3/2026 | $0 |
| | 2026 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01CA238523 | Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia | 000 | 5 | NIH | 3/30/2026 | $0 |
| | 2026 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01AI152044 | Role of Toll-like Receptor 9 in Fibroblastic Reticular Cell-based Therapy for Intra-abdominal Sepsis | 000 | 7 | NIH | 4/1/2026 | $0 |
| | 2026 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01AA028947 | Promotion of Alzheimers Disease by Alcohol - Role of eCIRP | 000 | 5 | NIH | 12/4/2025 | $0 |
| | 2026 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K23MH127300 | Striatal Function in Psychosis Relapse | 000 | 4 | NIH | 12/5/2025 | $0 |
| | 2026 | 2024 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | K01AR075097 | The Role of TNF in Breaking B Cell Tolerance | 000 | 5 | NIH | 2/19/2026 | $0 |
| | 2026 | 2023 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21MH126260 | Functional MRI in Schizophrenia | 000 | 2 | NIH | 1/23/2026 | -$5,591 |
| | 2026 | 2023 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R21AG082054 | Identifying diagnostic biomarkers for Delirium and predicting cognitive Outcomes in hospitalized older adults using automated Speech Analysis (IDOSA) | 000 | 1 | NIH | 3/9/2026 | $0 |
| | 2026 | 2023 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R03CA273478 | The Development and Psychometric Evaluation of the SIRS: A Social Isolation Risk Scale for Survivors of Head and Neck Cancer | 000 | 1 | NIH | 12/8/2025 | $0 |
| | 2026 | 2023 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01MH120594 | Early-phase Schizophrenia: Practice-based Research to Improve Treatment Outcomes (ESPRITO) | 000 | 5 | NIH | 11/20/2025 | -$98,113 |
| | 2026 | 2023 | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH | 350 COMMUNITY DR | MANHASSET | NY | 11030-3816 | NASSAU | USA | R01HL150040 | mTOR and VEGFR2 pathways in HHT pathogenesis | 000 | 4 | NIH | 12/22/2025 | $0 |
|
